David Krempa Insider Trades & Stock Holdings

Chief Business Officer · Eton Pharmaceuticals, Inc. · Latest filing Jun 26, 2026

David Krempa, Chief Business Officer at Eton Pharmaceuticals, Inc. has 1 Form 4 trade on file since Jun 26, 2026. Latest filing: acquired 10K shares of $ETON on Jun 26, 2026.

Trades on file: 1
Open-market bought: $0
Open-market sold: $0
Net open-market: $0
Latest filing: Jun 26, 2026

All insider trades by David Krempa

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 26, 2026	$ETON	Buy (Grant or award)	10K	$0	—			+6.5%	+18.5%		Chief Business Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks David Krempa traded

$ETON

Frequently asked questions

What was David Krempa's latest insider trade?

acquired 10K shares of $ETON on Jun 26, 2026.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text